Blog
Indiana Life Sciences Collaboration Conference Series Upcoming Event on May 8
As a sponsor of the 2014-2015 Indiana Life Sciences Collaboration Conference Series, Pearl Pathways would like to announce the upcoming conference entitled The Changing Role of the Consumer in Healthcare. We invite you to join us at the event on Friday, May 8, where a...
Pearl Pathways sponsoring, attending 6th Semi-Annual IVD Conference in San Diego
Pearl Pathways is excited to sponsor Q1 Productions’ and attend its upcoming IVD conference on Clinical Affairs and Regulatory Approvals for Diagnostics. The conference provides an excellent opportunity to network with industry experts and gain additional insight on...
Pearl IRB updated fee schedule in effect April 1, 2015
Please note that effective April 1, 2015, Pearl IRB has changed its fee schedule. To view pricing for your upcoming study, see our 2015 Fee Schedule. Please contact us at info@pearlirb.com for a price quote for Central IRB services, detailed pricing of your research...
FDA Releases Draft Guidance on Use of Electronic Information Consent in Clinical Studies
In order to present related information to a clinical study and acquire and document informed consent, electronic systems and processes such as text, audio, and graphics are increasingly being employed. According to FDA per their new draft guidance, this is referred...
Using Customer Data, 23andMe Plans to Invent its Own Drugs
23andMe, a DNA analysis service company who provides information and tools to individuals to learn more about their DNA has announced its plan to invent its own drugs using customer data. This drastic move will allow 23andMe to capitalize on the economic value its...